StageSeed VC | Alive
nanoRETE provides real-time detection of pathogens using customized nanoparticle biosensors. The company has developed a platform that has the ability to test for numerous pathogens (anthrax, E. Coli, salmonella, tuberculosis, etc.) using a simple-to-use handheld device which generates screening results in about one hour.
Missing: nanoRETE's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: nanoRETE's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing nanoRETE
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
nanoRETE is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
nanoRETE Frequently Asked Questions (FAQ)
Where is nanoRETE's headquarters?
nanoRETE's headquarters is located at 3815 Technology Blvd, Lansing.
What is nanoRETE's latest funding round?
nanoRETE's latest funding round is Seed VC.
How much did nanoRETE raise?
nanoRETE raised a total of $1.18M.
Who are the investors of nanoRETE?
Investors of nanoRETE include Charter Capital Partners and Global Food Protection Institute.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.